vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and BRC Group Holdings, Inc. (RILY). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $188.3M, roughly 1.9× BRC Group Holdings, Inc.). BRC Group Holdings, Inc. runs the higher net margin — 47.9% vs -0.8%, a 48.7% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -21.9%). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -15.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
ASIX vs RILY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $188.3M |
| Net Profit | $-2.8M | $90.3M |
| Gross Margin | 7.6% | 79.5% |
| Operating Margin | -0.7% | 32.3% |
| Net Margin | -0.8% | 47.9% |
| Revenue YoY | 9.4% | -21.9% |
| Net Profit YoY | -892.9% | 1710.8% |
| EPS (diluted) | $-0.11 | $2.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $188.3M | ||
| Q3 25 | $374.5M | $215.3M | ||
| Q2 25 | $410.0M | $188.2M | ||
| Q1 25 | $377.8M | $197.2M | ||
| Q4 24 | $329.1M | $241.0M | ||
| Q3 24 | $398.2M | $225.5M | ||
| Q2 24 | $453.5M | $256.0M | ||
| Q1 24 | $336.8M | $263.4M |
| Q4 25 | $-2.8M | $90.3M | ||
| Q3 25 | $-2.6M | $91.1M | ||
| Q2 25 | $31.4M | $139.5M | ||
| Q1 25 | $23.3M | $-10.0M | ||
| Q4 24 | $352.0K | $-5.6M | ||
| Q3 24 | $22.3M | $-284.4M | ||
| Q2 24 | $38.9M | $-433.6M | ||
| Q1 24 | $-17.4M | $-49.2M |
| Q4 25 | 7.6% | 79.5% | ||
| Q3 25 | 6.8% | 83.7% | ||
| Q2 25 | 14.3% | 81.3% | ||
| Q1 25 | 14.2% | 81.4% | ||
| Q4 24 | 3.4% | 79.8% | ||
| Q3 24 | 14.4% | 82.1% | ||
| Q2 24 | 17.9% | 84.5% | ||
| Q1 24 | 0.9% | 85.3% |
| Q4 25 | -0.7% | 32.3% | ||
| Q3 25 | -0.9% | 30.4% | ||
| Q2 25 | 7.7% | 5.7% | ||
| Q1 25 | 7.7% | -31.2% | ||
| Q4 24 | -3.9% | -69.2% | ||
| Q3 24 | 7.5% | -36.4% | ||
| Q2 24 | 11.5% | -90.8% | ||
| Q1 24 | -7.0% | -6.1% |
| Q4 25 | -0.8% | 47.9% | ||
| Q3 25 | -0.7% | 42.3% | ||
| Q2 25 | 7.7% | 74.1% | ||
| Q1 25 | 6.2% | -5.1% | ||
| Q4 24 | 0.1% | -2.3% | ||
| Q3 24 | 5.6% | -126.1% | ||
| Q2 24 | 8.6% | -169.4% | ||
| Q1 24 | -5.2% | -18.7% |
| Q4 25 | $-0.11 | $2.78 | ||
| Q3 25 | $-0.10 | $2.91 | ||
| Q2 25 | $1.15 | $4.50 | ||
| Q1 25 | $0.86 | $-0.39 | ||
| Q4 24 | $0.02 | $-0.01 | ||
| Q3 24 | $0.82 | $-9.39 | ||
| Q2 24 | $1.43 | $-14.35 | ||
| Q1 24 | $-0.65 | $-1.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $226.6M |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $815.2M | $-171.5M |
| Total Assets | $1.7B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $226.6M | ||
| Q3 25 | $23.7M | $184.2M | ||
| Q2 25 | $18.4M | $267.4M | ||
| Q1 25 | $8.3M | $138.3M | ||
| Q4 24 | $19.6M | $146.9M | ||
| Q3 24 | $17.3M | $159.2M | ||
| Q2 24 | $12.1M | $236.9M | ||
| Q1 24 | $20.6M | $190.7M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $815.2M | $-171.5M | ||
| Q3 25 | $818.2M | $-260.5M | ||
| Q2 25 | $823.7M | $-351.7M | ||
| Q1 25 | $794.4M | $-496.8M | ||
| Q4 24 | $774.6M | $-488.2M | ||
| Q3 24 | $766.4M | $-497.6M | ||
| Q2 24 | $746.6M | $-218.3M | ||
| Q1 24 | $713.2M | $228.4M |
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.6B | $1.8B | ||
| Q3 24 | $1.5B | $2.2B | ||
| Q2 24 | $1.5B | $3.2B | ||
| Q1 24 | $1.5B | $5.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $26.2M |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | 0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $26.2M | ||
| Q3 25 | $26.6M | $-60.6M | ||
| Q2 25 | $21.1M | $-25.6M | ||
| Q1 25 | $11.4M | $184.0K | ||
| Q4 24 | $64.2M | $-2.7M | ||
| Q3 24 | $57.3M | $19.5M | ||
| Q2 24 | $50.2M | $111.5M | ||
| Q1 24 | $-36.2M | $135.4M |
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | 0.67× | -0.18× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
